<bill session="116" type="h" number="4974" updated="2022-11-01T04:47:40Z">
  <state datetime="2019-11-01">REFERRED</state>
  <status>
    <introduced datetime="2019-11-01"/>
  </status>
  <introduced datetime="2019-11-01"/>
  <titles>
    <title type="display">MATE Act of 2019</title>
    <title type="official" as="introduced">To amend the Controlled Substances Act to require physicians and other prescribers of controlled substances to complete training on treating and managing patients with opioid and other substance use disorders (which shall also satisfy certain training required to receive a waiver for dispensing narcotic drugs for maintenance or detoxification treatment), and for other purposes.</title>
    <title type="short" as="introduced">MATE Act of 2019</title>
    <title type="short" as="introduced">Medication Access and Training Expansion Act of 2019</title>
  </titles>
  <sponsor bioguide_id="T000482"/>
  <cosponsors>
    <cosponsor bioguide_id="A000378" joined="2020-03-05"/>
    <cosponsor bioguide_id="B001300" joined="2020-02-10"/>
    <cosponsor bioguide_id="B001301" joined="2019-11-01"/>
    <cosponsor bioguide_id="B001303" joined="2020-03-02"/>
    <cosponsor bioguide_id="C001103" joined="2019-11-01"/>
    <cosponsor bioguide_id="C001117" joined="2020-03-02"/>
    <cosponsor bioguide_id="C001067" joined="2020-02-10"/>
    <cosponsor bioguide_id="C001124" joined="2020-02-07"/>
    <cosponsor bioguide_id="C001121" joined="2019-11-01"/>
    <cosponsor bioguide_id="E000179" joined="2020-03-05"/>
    <cosponsor bioguide_id="H001090" joined="2020-01-24"/>
    <cosponsor bioguide_id="H001081" joined="2020-01-24"/>
    <cosponsor bioguide_id="J000032" joined="2020-04-21"/>
    <cosponsor bioguide_id="K000394" joined="2020-02-21"/>
    <cosponsor bioguide_id="K000382" joined="2019-11-01"/>
    <cosponsor bioguide_id="N000179" joined="2020-06-15"/>
    <cosponsor bioguide_id="P000614" joined="2019-11-01"/>
    <cosponsor bioguide_id="R000395" joined="2019-11-01"/>
    <cosponsor bioguide_id="R000613" joined="2019-11-01"/>
    <cosponsor bioguide_id="S001216" joined="2020-01-24"/>
    <cosponsor bioguide_id="T000469" joined="2019-11-01"/>
    <cosponsor bioguide_id="T000483" joined="2019-11-01"/>
    <cosponsor bioguide_id="W000800" joined="2020-02-06"/>
  </cosponsors>
  <actions>
    <action datetime="2019-11-01">
      <text>Introduced in House</text>
    </action>
    <action datetime="2019-11-01" state="REFERRED">
      <text>Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="2019-11-01">
      <text>Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="2019-11-04">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
    <action datetime="2019-12-18">
      <text>Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.</text>
    </action>
  </actions>
  <committees>
    <committee code="HSJU" name="House Judiciary" subcommittee="" activity="Referral"/>
    <committee code="HSJU08" name="House Judiciary" subcommittee="Crime and Federal Government Surveillance" activity="Referral"/>
    <committee code="HSIF" name="House Energy and Commerce" subcommittee="" activity="Referral"/>
    <committee code="HSIF14" name="House Energy and Commerce" subcommittee="Health" activity="Referral"/>
  </committees>
  <relatedbills>
    <bill session="116" type="s" number="4640" relation="unknown"/>
  </relatedbills>
  <subjects>
    <term name="Health"/>
    <term name="Administrative law and regulatory procedures"/>
    <term name="Alternative treatments"/>
    <term name="Department of Health and Human Services"/>
    <term name="Drug safety, medical device, and laboratory regulation"/>
    <term name="Drug therapy"/>
    <term name="Drug trafficking and controlled substances"/>
    <term name="Drug, alcohol, tobacco use"/>
    <term name="Employment and training programs"/>
    <term name="Health personnel"/>
    <term name="Higher education"/>
    <term name="Licensing and registrations"/>
    <term name="Medical education"/>
    <term name="Nursing"/>
    <term name="Prescription drugs"/>
    <term name="Teaching, teachers, curricula"/>
  </subjects>
  <amendments/>
  <summary date="2020-12-28T15:42:10Z" status="Introduced in House">Medication Access and Training Expansion Act of 2019 or the MATE Act of 2019

This bill requires prescribers of controlled substances, as a condition of obtaining or renewing their registration with the Drug Enforcement Administration, to complete specified education or training on the prevention, treatment, and management of opioid-use and other substance-use disorders. This education and training shall also satisfy the training requirements currently needed to obtain waivers to prescribe certain medication-assisted treatments for opioid-use disorders in settings other than opioid treatment programs.</summary>
</bill>
